The market showed a small loss Friday, and UK 100 (CBOE) ended the day at 820 points, which is a decline of 0.4 percent. The week as a whole showed a gain of 1.0 percent. 719 shares showed a gain and 1027 showed a loss. 154 shares were unchanged and closed at the same price as the previous day. There was no trading in 227 shares. Total value of the trading volume for shares and primary capital certificates Friday was approximately 1513.9 billion. | |
SOCIETE GENERALE ACCEPTANC | 90.48% |
SOCIETE GENERALE ACCEPTANC | 52.89% |
Crimson Tide Plc | 51.43% |
SOCIETE GENERALE ACCEPTANC | 43.97% |
SOCIETE GENERALE ACCEPTANC | 43.12% |
AIQ Limited | -59.44% |
SOCIETE GENERALE ACCEPTANC | -55.79% |
SOCIETE GENERALE ACCEPTANC | -48.78% |
SOCIETE GENERALE ACCEPTANC | -44.60% |
SOCIETE GENERALE ACCEPTANC | -40.75% |
AstraZeneca | 77192.08 |
Shell Plc | 65265.89 |
HSBC Holdings PLC | 61470.57 |
NatWest Group Plc | 42442.67 |
BP PLC | 40854.77 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.